Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma

Cancer Genetics and Cytogenetics

Volumn 172, Issue 2, 2007, Pages 158-164

  Sathanoori, Malini ^a,b   Shekhter Levin, Sofia ^a,b,c   Marks, Stanley M ^d   Swerdlow, Steven H ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ANEMIA; ARTICLE; BLOOD ANALYSIS; BONE MARROW; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME ARM; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE TRANSLOCATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; KARYOTYPING; LEUKOCYTOSIS; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; SPLEEN; SPLENOMEGALY; THROMBOCYTOPENIA;

ALLELIC IMBALANCE; BONE MARROW NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CYCLIN D1; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; SPLENIC NEOPLASMS; TRANSLOCATION, GENETIC; VARIATION (GENETICS);

BLASTOIDEA;

EID: 33846013974     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.09.005     Document Type: Article

References (25)

1. Swerdlow S.H., Berger F., Isaacson P.I., Müller-Hemelink H.K., Nathwani B.N., Piris M.A., and Harris N.L. Mantle cell lymphoma. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours (2001), IARC Press, Lyon 168-170
2. Williams M.E., Swerdlow S.H., Rosenberg C.L., and Arnold A. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 7 (1993) 241-245
3. Oka K., Ohno T., Yamaguchi M., Mahmud N., Miwa H., Kita K., Shiku H., and Shirakawa S. PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma. Leuk Lymphoma 21 (1996) 37-42
4. Rimokh R., Berger F., Delsol G., Digonnet I., Rouault J.P., Tigaud J.D., Gadoux M., Coiffier B., Bryon P.A., and Magaud J.P. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 83 (1994) 1871-1875
5. Callanan M., Leroux D., Magaud J.P., and Rimokh R. Implication of cyclin D1 in malignant lymphoma. Crit Rev Oncog 7 (1996) 191-203
6. Bertoni F., Zucca E., and Cotter F.E. Molecular basis of mantle cell lymphoma. Br J Haematol 124 (2004) 130-140
7. Swerdlow S.H., and Williams M.E. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol 33 (2002) 7-20 Review
8. Campo E., Raffeld M., and Jaffe E.S. Mantle-cell lymphoma. Semin Hematol 36 (1999) 115-127 Review
9. Cuneo A., Bigoni R., Rigolin G.M., Roberti M.G., Bardi A., Piva N., Milani R., Bullrich F., Veronese M.L., Croce C., Birg F., Dohner H., Hagemeijer A., and Castoldi G. Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. Blood 93 (1999) 1372-1380
10. Coignet L.J., Schuuring E., Kibbelaar R.E., Raap T.K., Kleiverda K.K., Bertheas M.F., Wiegant J., Beverstock G., and Kluin P.M. Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization. Blood 87 (1996) 1512-1519
11. Maravelaki S., Burford A., Wotherspoon A., Joshi R., Matutes E., Catovsky D., and Brito-Babapulle V. Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region. Cancer Genet Cytogenet 154 (2004) 67-71
12. Aamot H.V., Tjonnfjord G.E., Delabie J., and Heim S. Molecular cytogenetic analysis of leukemic mantle cell lymphoma with a cryptic t(11;14). Cancer Genet Cytogenet 165 (2006) 172-175
13. Rosenwald A., Wright G., Wiestner A., Chan W.C., Connors J.M., Campo E., Gascoyne R.D., Grogan T.M., Muller-Hermelink H.K., Smeland E.B., Chiorazzi M., Giltnane J.M., Hurt E.M., Zhao H., Averett L., Henrickson S., Yang L., Powell J., Wilson W.H., Jaffe E.S., Simon R., Klausner R.D., Montserrat E., Bosch F., Greiner T.C., Weisenburger D.D., Sanger W.G., Dave B.J., Lynch J.C., Vose J., Armitage J.O., Fisher R.I., Miller T.P., LeBlanc M., Ott G., Kvaloy S., Holte H., Delabie J., and Staudt L.M. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3 (2003) 185-197
14. Chesi M., Bergsagel P.L., Brents L.A., Smith C.M., Gerhard D.S., and Kuehl W.M. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 88 (1996) 674-681
15. Aventin A., Nomdedeu J., Briones J., Espinosa I., Bordes R., and Sierra J. Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14. J Clin Pathol 56 (2003) 798-800
16. Gabrea A., Bergsagel P.L., Chesi M., Shou Y., and Kuehl W.M. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. Mol Cell 3 (1999) 119-123
17. Bosch F., Jares P., Campo E., Lopez-Guillermo A., Piris M.A., Villamor N., Tassies D., Jaffe E.S., Montserrat E., and Rozman C. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 84 (1994) 2726-2732
18. Cook J.R., Hsi E.D., Worley S., Tubbs R.R., and Hussein M. Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival. Am J Clin Pathol 125 (2006) 615-624
19. Sherer M.E., Shekhter-Levin S., Krause J.R., Joyce R.A., and Gollin S.M. Atypical (7;19) translocation in acute myelomonocytic leukemia. Cancer Genet Cytogenet 57 (1991) 169-173
20. ISCN 2005: an international system for human cytogenetic nomenclature (2005). In: Shaffer L.G., and Tommerup N. (Eds) (2005), S. Karger, Basel
21. Rimokh R., Berger F., Bastard C., Klein B., French M., Archimbaud E., Rouault J.P., Santa Lucia B., Duret L., and Vuillaume M. Rearrangement of CCND1 (BCL1/PRAD1) 3′ untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood 83 (1994) 3689-3696
22. Au W.Y., Gascoyne R.D., Viswanatha D.S., Connors J.M., Klasa R.J., and Horsman D.E. Cytogenetic analysis in mantle cell lymphoma: a review of 214 cases. Leuk Lymphoma 43 (2002) 783-791
23. Hernandez L., Fest T., Cazorla M., Teruya-Feldstein J., Bosch F., Peinado M.A., Piris M.A., Montserrat E., Cardesa A., Jaffe E.S., Campo E., and Raffeld M. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 87 (1996) 3351-3359
24. Koduru P.R., Raju K., Vadmal V., Menezes G., Shah S., Susin M., Kolitz J., and Broome J.D. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. Blood 90 (1997) 4078-4091
25. Espinet B., Sole F., Woessner S., Bosch F., Florensa L., Campo E., Costa D., Lloveras E., Vila R.M., Besses C., Montserrat E., and Sans-Sabrafen J. Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma. Cancer Genet Cytogenet 111 (1999) 92-98